Cerebel (EGF111438): An Open Label Randomized Phase III...

Cerebel (EGF111438): An Open Label Randomized Phase III Study Comparing the Incidence of CNS Metastases in Patients (PTS) with HER2+ Metastatic Breast Cancer (MBC), Treated with Lapatinib Plus Capecitabine (LC) Versus Trastuzumab Plus Capecitabine (TC)

Pivot, X., Semiglazov, V., Żurawski, B., Allerton, R., Fabi, A., Ciruelos, E., Parikh, R., DeSilvio, M., Santillana, S., Swaby, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)34361-1
Date:
September, 2012
File:
PDF, 58 KB
2012
Conversion to is in progress
Conversion to is failed